Sat, Sep 20, 2014, 11:11 AM EDT - U.S. Markets closed

Recent

% | $
Quotes you view appear here for quick access.

Celgene Corp. (CELG) Message Board

  • rob_cos rob_cos Mar 8, 2013 10:10 AM Flag

    Short term...long term

    Its so tough after a run like this to figure out where this is going. I always try to think after runs like this what the bears could hit us with. Near term there is not a lot of catalysts - the possible positives this yr could be huge - there could be a couple of smaller negatives near term. So if anyone is thinking of adding calls - make sure you go out to October.

    Short term its pretty clear the Q1 Revlimid numbers may be a bit high. Analysts never took them down despite the company disclosing the very real $100 million Revlimid currency issue disclosed at JPM (would have been a negative but was overshadowed greatly by the stunning 2017 guidance. Will anyone care now that we have other drugs hitting it and I believe EPS will beat nicely. Analysts are saying the generic Vidaza I said yrs ago would not come as early as people thought, might finally happen this yr. That could come out of nowhere - but company only has 2 quarters in guidance without it and so that is about assured since we didnt hear yet. An announcement would hurt the stock briefly - as this is a nice windfall each quarter that can cover up shortfalls elsewhere. It looks like company will have MM015 this quarter but we will not hear about it - that trial scares people because bears always seem to find something they like in it and it was the source of the worse SPM issue. But to me there is a better chance it is a positive. But its unclear when we hear - might not be until ASH although I hope sooner. MM-020 is now pushed to maybe September - to me this is great news - as this makes it much more likely that we have positive data - but this is the biggest catalyst (some see it as a binary event)- now likely 6 months away. I think we could be over $130 on this data if positive. The EPS could be great. But we have to wait. There are many other positive catalysts coming - heck we might even get an authorization item to increase shares in the proxy - hinting of a split? The May 6th R&D meeting

    SortNewest  |  Oldest  |  Most Replied Expand all replies
    • rob question about leaps. Which strike do you take for the 2015 leaps? THanks

    • Full post didnt post..... The May 6th R&D meeting will be more important than people think.

      VERY short term I am a little cautious that on this Friday CELG and the market may have peaked for the next week or so - Friday's seem great - and Monday's not so much - S&P got very close to my 1550. Heck it might make it to 1565 or so - but I am a little cautious that a pullback may come - and it won't last but its overdue. How many days in a row can a market and CELG be up? Still the "going from one billion $ a drug to five billion $ a yr drugs" theme I have talked about for 2 yrs now is a virtual certainty now. The "Indication and International expansion and industry high GP% and industry low tax rate" thesis is playing out and will do so even more so next 2 yrs. Stock is still cheap on a PEG basis. I just post a little caution near term - only because I have been getting a series of emails and PMs that people are loading near term calls and adding trading shares - that makes me cringe a bit. Core shares or LEAPS I guess ok, I am looking to add 2015 LEAPS if mkt takes CELG down. The future has never been bright, but if you are adding here I am not sure near term items are best. I still see $200 by 2015 and $300 plus by 2017 - so I would hold every single share you have and lock it away forever. Just very near term - the emails and PMs I am getting make me a little worried. I was telling everyone to buy trading shares and LEAPS and calls in the 70s, 80, 90s. Perhaps its not time to buy them now -- I took my near term calls off today. I don't expect that 100+ Dow future indication to hold. Even mega bull Cramer just said "Take your profits and go home"

 
CELG
93.85+0.58(+0.62%)Sep 19 4:00 PMEDT

Trending Tickers

i
Trending Tickers features significant U.S. stocks showing the most dramatic increase in user interest in Yahoo Finance in the previous hour over historic norms. The list is limited to those equities which trade at least 100,000 shares on an average day and have a market cap of more than $300 million.